{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T21:17:52Z","timestamp":1775510272688,"version":"3.50.1"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.ijantimicag.2011.09.003","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T20:31:15Z","timestamp":1318883475000},"page":"21-35","source":"Crossref","is-referenced-by-count":23,"special_numbering":"S","title":["Antibiotic treatment of uncomplicated urinary tract infection in premenopausal women"],"prefix":"10.1016","volume":"38","author":[{"given":"Kurt G.","family":"Naber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Wullt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian M.E.","family":"Wagenlehner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0005","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/520427","article-title":"Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA)","volume":"29","author":"Warren","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0010","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1111\/j.1532-5415.2001.49268.x","article-title":"Efficacy and safety of ciprofloxacin oral suspension versus trimethoprim\u2013sulfamethoxazole oral suspension for treatment of older women with acute urinary tract infection","volume":"49","author":"Gomolin","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0015","first-page":"85","article-title":"Comparative study of single-dose and three-day therapy for acute uncomplicated cystitis","volume":"45","author":"Goto","year":"1999","journal-title":"Hinyokika Kiyo"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0020","first-page":"CD003597","article-title":"Quinolones for uncomplicated acute cystitis in women","volume":"3","author":"Rafalsky","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0025","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.amjmed.2005.02.005","article-title":"Three-day vs longer duration of antibiotic treatment for cystitis in women: systematic review and meta-analysis","volume":"118","author":"Katchman","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0030","first-page":"CD001535","article-title":"Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women","volume":"3","author":"Lutters","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jinf.2008.12.009","article-title":"Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials","volume":"58","author":"Falagas","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0040","unstructured":"US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. 1992:115\u201327."},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0045","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1166-7087(07)92383-0","article-title":"Evidence-based medicine overview of the main steps for developing and grading guideline recommendations","volume":"17","author":"Abrams","year":"2007","journal-title":"Prog Urol"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0050","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/00365540410019642","article-title":"The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study","volume":"36","author":"Ferry","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/02813430601183074","article-title":"Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project","volume":"25","author":"Ferry","year":"2007","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0060","first-page":"729","article-title":"Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women","volume":"52","author":"Christiaens","year":"2002","journal-title":"Br J Gen Pract"},{"issue":"Suppl. 4","key":"10.1016\/j.ijantimicag.2011.09.003_bib0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2165\/00003495-199100424-00005","article-title":"Single dose oral administration of cefixime 400mg in the treatment of acute uncomplicated cystitis and gonorrhoea","volume":"42","author":"Asbach","year":"1991","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0070","first-page":"695","article-title":"Sulphadimidine, co-trimoxazole, and a placebo in the management of symptomatic urinary tract infection in general practice","volume":"22","author":"Brooks","year":"1972","journal-title":"J R Coll Gen Pract"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0075","first-page":"90","article-title":"Treatment of urinary infection with a single dose of co-trimoxazole compared with a single dose of amoxicillin and a placebo","volume":"112","author":"Dubi","year":"1982","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jac\/dkg028","article-title":"An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project","volume":"51","author":"Kahlmeter","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2011.09.003_bib0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0924-8579(03)00229-2","article-title":"Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study","volume":"22","author":"Kahlmeter","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0090","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.eururo.2008.05.010","article-title":"Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy","volume":"54","author":"Naber","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0095","unstructured":"Institute. CLSI. Methods for dilution antimicrobial susceptibility testing. In: Institute. CLSI, editor. 17th informational supplement. PA, USA: Clinical and Laboratory Standards Institute; 2007."},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00042307-199901000-00010","article-title":"Short-term therapy of acute uncomplicated cystitis","volume":"9","author":"Naber","year":"1999","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1179\/joc.2005.17.3.251","article-title":"Antimicrobial susceptibility patterns of contemporary pathogens from uncomplicated urinary tract infections isolated in a multicenter Italian survey: possible impact on guidelines","volume":"17","author":"Fadda","year":"2005","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0110","first-page":"399","article-title":"Single-dose treatment of cystitis with fosfomycin trometamol (Monuril): analysis of 15 comparative trials on 2.048 patients","volume":"19","author":"Lecomte","year":"1997","journal-title":"Giorn It Ost Gin"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0924-8579(98)00021-1","article-title":"A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women","volume":"10","author":"Minassian","year":"1998","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0120","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0149-2918(00)86734-X","article-title":"Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection","volume":"21","author":"Stein","year":"1999","journal-title":"Clin Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2011.09.003_bib0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jac\/46.suppl_1.35","article-title":"Pivmecillinam in the treatment of urinary tract infections","volume":"46","author":"Nicolle","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0130","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/00365540110080728","article-title":"Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women","volume":"34","author":"Nicolle","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0924-8579(02)00171-1","article-title":"Symptomatic vaginal candidiasis after pivmecillinam and norfloxacin treatment of acute uncomplicated lower urinary tract infection","volume":"20","author":"Menday","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0140","unstructured":"(L\u00e4kemedelsverket) SMPA. Guidelines for treatment of uncomplicated female UTI (Swedish title: Behandlingsrekommendationer vid nedre okomplicerad UVI). L\u00e4kemedelsverket 2007;18:8\u201315."},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0145","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1365-2125.2004.02106.x","article-title":"Increased treatment failure after 3-days\u2019 courses of nitrofurantoin and trimethoprim for urinary tract infections in women: a population-based retrospective cohort study using the PHARMO database","volume":"58","author":"Goettsch","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl. A","key":"10.1016\/j.ijantimicag.2011.09.003_bib0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jac\/33.suppl_A.121","article-title":"Nitrofurantoin modified release versus trimethoprim or co-trimoxazole in the treatment of uncomplicated urinary tract infection in general practice","volume":"33","author":"Spencer","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0155","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1001\/archinte.167.20.2207","article-title":"Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women","volume":"167","author":"Gupta","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0160","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00019048-200009080-00006","article-title":"A double-blind, randomized trial of the efficacy and safety of shortcourse, once-daily levofloxacin versus ofloxacin twice daily in uncomplicated urinary tract infection","volume":"9","author":"Richard","year":"1998","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0165","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jama.293.8.949","article-title":"Amoxicillin\u2013clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial","volume":"293","author":"Hooton","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0170","first-page":"17","article-title":"Classification of the oral cephalosporins","volume":"18","author":"Scholz","year":"2000","journal-title":"Arzneimitteltherapie"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0175","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF01739308","article-title":"Cefuroxime axetil versus ofloxacin for short-term therapy of acute uncomplicated lower urinary tract infections in women","volume":"21","author":"Naber","year":"1993","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0180","unstructured":"e.V. DIfN, Medizinische Mikrobiologie - Empfindlichkeitspr\u00fcfung von mikrobiellen Krankheitserregern gegen Chemotherapeutika - Teil 4: Bewertungsstufen f\u00fcr die minimalen Hemmkonzentrationen \u2013 MHK Grenzwerte - von antibakteriellen Wirkstoffen. In Beiblatt zu DIN 58940-1, e.V. DIfN, editors. Berlin: Beuth; August 2005."},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0185","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0149-2918(00)80054-5","article-title":"Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection","volume":"22","author":"Leigh","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0190","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1128\/AAC.47.3.897-900.2003","article-title":"Cefpodoxime-proxetil versus trimethoprim\u2013sulfamethoxazole for short-term therapy of uncomplicated acute cystitis in women","volume":"47","author":"Kavatha","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0195","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0924-8579(02)00104-8","article-title":"Outcomes associated with trimethoprim\/sulphamethoxazole (TMP\/SMX) therapy in TMP\/SMX resistant community-acquired UTI","volume":"19","author":"Gupta","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0200","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1086\/339812","article-title":"Empiric use of trimethoprim\u2013sulfamethoxazole (TMP\u2013SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP\u2013SMX resistant uropathogens","volume":"34","author":"Raz","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0205","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1086\/427507","article-title":"Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults","volume":"40","author":"Nicolle","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0210","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0022-5347(17)48870-7","article-title":"Therapy of symptomatic pyelonephritis in women","volume":"133","author":"Gleckman","year":"1985","journal-title":"J Urol"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0215","doi-asserted-by":"crossref","first-page":"341","DOI":"10.7326\/0003-4819-106-3-341","article-title":"Acute renal infection in women: treatment with trimethoprim\u2013sulfamethoxazole or ampicillin for two or six weeks. A randomized trial","volume":"106","author":"Stamm","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0220","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.0954-6820.1980.tb09725.x","article-title":"Failure of excessive doses of ampicillin to prevent bacterial relapse in the treatment of acute pyelonephritis","volume":"207","author":"Ode","year":"1980","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0225","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.0954-6820.1988.tb15899.x","article-title":"One or three weeks\u2019 treatment of acute pyelonephritis? A double-blind comparison, using a fixed combination of pivampicillin plus pivmecillinam","volume":"223","author":"Jernelius","year":"1988","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0230","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/infdis\/163.2.325","article-title":"Therapy for women hospitalized with acute pyelonephritis: a randomized trial of ampicillin versus trimethoprim-sulfamethoxazole for 14 days","volume":"163","author":"Johnson","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0235","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/003655401750173922","article-title":"Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime","volume":"33","author":"Cronberg","year":"2001","journal-title":"Scand J Infect Dis"},{"issue":"Suppl. B","key":"10.1016\/j.ijantimicag.2011.09.003_bib0240","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/jac\/32.suppl_B.123","article-title":"Low-dosage cefepime as treatment for serious bacterial infections","volume":"32","author":"Giamarellou","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0245","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1185\/030079907X233340","article-title":"A trial of levofloxacin 750mg once daily for 5 days versus ciprofloxacin 400mg and\/or 500mg twice daily for 10 days in the treatment of acute pyelonephritis","volume":"23","author":"Klausner","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"Suppl. A","key":"10.1016\/j.ijantimicag.2011.09.003_bib0250","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jac\/36.suppl_A.145","article-title":"Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group","volume":"36","author":"Mouton","year":"1995","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2011.09.003_bib0255","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.ijantimicag.2003.09.002","article-title":"Gatifloxacin 200mg or 400mg once daily is as effective as ciprofloxacin 500mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections","volume":"23","author":"Naber","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0260","first-page":"29","article-title":"Cefpodoxime proxetil in patients with acute uncomplicated pyelonephritis. International, prospective, randomized comparative study versus ciprofloxacin in general practice","volume":"10","author":"Naber","year":"2001","journal-title":"Chemother J"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0265","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.urology.2007.09.002","article-title":"A double-blind, randomized comparison of levofloxacin 750mg once-daily for five days with ciprofloxacin 400\/500mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis","volume":"71","author":"Peterson","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0270","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0090-4295(98)00160-5","article-title":"Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis","volume":"52","author":"Richard","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0275","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/emj.19.1.19","article-title":"Short-term effectiveness of ceftriaxone single dose in the initial treatment of acute uncomplicated pyelonephritis in women. A randomized controlled trial","volume":"19","author":"Sanchez","year":"2002","journal-title":"Emerg Med J"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0280","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/01.ju.0000106191.11936.64","article-title":"Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis","volume":"171","author":"Talan","year":"2004","journal-title":"J Urol"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2011.09.003_bib0285","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.ijantimicag.2003.12.005","article-title":"Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections","volume":"23","author":"Talan","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0290","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jama.283.12.1583","article-title":"Comparison of ciprofloxacin (7 days) and trimethoprim\u2013sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial","volume":"283","author":"Talan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0295","unstructured":"Grabe M (chairman) BM, Bjerklund-Johansen TE, Botto H, Cek M, Lobel B, Naber KG, et al., Guidelines on the management of urinary and male genital tract infections. In: Urology EAo, editor. European Association of Urology Guidelines. The Netherlands: European Association of Urology Arnhem; 2008. p. 1\u2013116."},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0300","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0195-6701(98)90274-2","article-title":"Community-acquired urinary tract infection in adults: a hospital viewpoint","volume":"38","author":"Finkelstein","year":"1998","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0305","first-page":"50","article-title":"Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women","volume":"8","author":"Auquer","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0310","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0002-9343(99)00026-1","article-title":"A randomized trial of shortcourse ciprofloxacin, ofloxacin, or trimethoprim\/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group","volume":"106","author":"McCarty","year":"1999","journal-title":"Am J Med"},{"issue":"Suppl. A","key":"10.1016\/j.ijantimicag.2011.09.003_bib0315","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jac\/43.suppl_1.67","article-title":"A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection","volume":"43","author":"Iravani","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0320","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/archinte.1995.00430050061007","article-title":"Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group","volume":"155","author":"Iravani","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0325","first-page":"469","article-title":"Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial","volume":"170","author":"Vogel","year":"2004","journal-title":"CMAJ"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0330","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/jac\/dkh414","article-title":"Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim\/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study","volume":"54","author":"Arredondo-Garcia","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0335","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/S0149-2918(02)80099-6","article-title":"Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women","volume":"24","author":"Henry","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0340","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1128\/AAC.49.10.4137-4143.2005","article-title":"Efficacy and safety of a novel once-daily extended release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women","volume":"49","author":"Fourcroy","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0345","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1128\/AAC.33.6.877","article-title":"Singledose enoxacin compared with 3-day treatment for urinary tract infection","volume":"33","author":"Backhouse","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0350","doi-asserted-by":"crossref","first-page":"89S","DOI":"10.1016\/S0002-9343(20)31145-1","article-title":"Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections","volume":"94","author":"Iravani","year":"1993","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0355","series-title":"7th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)","article-title":"Fleroxacin in the treatment of uncomplicated urinary tract infections in women","author":"Iravani","year":"1995"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2011.09.003_bib0360","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1007\/BF01643434","article-title":"A general practitioner multicenter study: fosfomycin trometamol single dose versus pipemidic acid multiple dose","volume":"18","author":"Jardin","year":"1990","journal-title":"Infection"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2011.09.003_bib0365","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1007\/BF01643433","article-title":"Fosfomycin trometamol in a single dose versus norfloxacin for seven days in the treatment of uncomplicated urinary infections in general practice","volume":"18","author":"Boerema","year":"1990","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0370","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000282164","article-title":"Single-dose fosfomycin trometamol (Monuril) versus multiple-dose norfloxacin: results of a multicenter study in females with uncomplicated lower urinary tract infections","volume":"46","author":"de Jong","year":"1991","journal-title":"Urol Int"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0375","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF01871127","article-title":"Fosfomycin trometamol in a single dose versus seven days nitrofurantoin in the treatment of acute uncomplicated urinary tract infections in women","volume":"15","author":"Van Pienbroek","year":"1993","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0380","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0399-077X(96)80209-5","article-title":"Le traitement monodose de la cystite par fosfomycin trometamol. Analyse de 15 essais comparatives portant sur 2048 malades","volume":"26","author":"Lecomte","year":"1996","journal-title":"M\u00e9decine et Maladies infectieuses"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0385","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000085625","article-title":"Fosfomycin tromethamine in uncomplicated urinary tract infections: a clinical study","volume":"51","author":"Bonfiglio","year":"2005","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0390","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0090-4295(01)01562-X","article-title":"Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens","volume":"59","author":"Richard","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0395","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ijantimicag.2003.12.017","article-title":"Gatifloxacin 400mg as a single shot or 200mg once daily for 3 days is as effective as ciprofloxacin 250mg twice daily for the treatment of patients with uncomplicated urinary tract infections","volume":"23","author":"Naber","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0400","unstructured":"Richard G dC, Ruoff G, Corrado M, Fowler C. Short-course levofloxacin (250mg qid) vs ofloxacin (200mg bid) in uncomplicated UTI: a double-blind, randomized trial. In: 6th Int Symp New Quinolones. Nov 15\u201317, Denver, Colorado, USA; 1998 [Abstract]."},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0405","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3109\/00365549209062463","article-title":"Lomefloxacin versus norfloxacin in the treatment of uncomplicated urinary tract infections: three-day versus sevenday treatment. The South Swedish Lolex Study Group","volume":"24","author":"Neringer","year":"1992","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0410","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1128\/AAC.37.3.574","article-title":"Treatment of acute uncomplicated urinary tract infections with 3 days of lomefloxacin compared with treatment with 3 days of norfloxacin","volume":"37","author":"Nicolle","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0415","doi-asserted-by":"crossref","unstructured":"Double-blind comparison of 3-day versus 7-day treatment with norfloxacin in symptomatic urinary tract infections. The Inter-Nordic Urinary tract Infection Study Group. Scand J Infect Dis 1988;20:619\u201324.","DOI":"10.3109\/00365548809035662"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0420","first-page":"644","article-title":"Three-day versus seven-day treatment with norfloxacin in acute cystitis","volume":"47","author":"Piipo","year":"1990","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0425","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1179\/joc.1998.10.2.122","article-title":"Efficacy and safety of norfloxacin 800mg oncedaily versus norfloxacin 400mg twicedaily in the treatment of uncomplicated urinary tract infections in women: a double-blind, randomized clinical trial","volume":"10","author":"Pimentel","year":"1998","journal-title":"J Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2011.09.003_bib0430","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2165\/00003495-198700341-00022","article-title":"Ofloxacin versus trimethoprim\u2013sulphamethoxazole in acute cystitis","volume":"34","author":"Block","year":"1987","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0435","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1128\/AAC.33.8.1308","article-title":"Ofloxacin versus trimethoprim\u2013sulfamethoxazole for treatment of acute cystitis","volume":"33","author":"Hooton","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0440","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1128\/AAC.35.7.1479","article-title":"Single-dose and threeday regimens of ofloxacin versus trimethoprim\u2013sulfamethoxazole for acute cystitis in women","volume":"35","author":"Hooton","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0445","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0924-8579(94)90009-4","article-title":"Pefloxacin single-dose in the treatment of acute uncomplicated lower urinary tract infections in women: a meta-analysis of seven clinical trials","volume":"4","author":"Naber","year":"1994","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0450","first-page":"587","article-title":"Quinolones for short-term treatment of uncomplicated urinary tract infection","volume":"76","author":"Kadiri","year":"1999","journal-title":"East Afr Med J"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0455","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0924-8579(99)00118-1","article-title":"Comparison of pivmecillinam and cephalexin in acute uncomplicated urinary tract infection","volume":"13","author":"Menday","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0460","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/AAC.39.1.215","article-title":"Randomized, double-blind comparison of single-dose regimens of rufloxacin and pefloxacin for acute uncomplicated cystitis in women. French Multicenter Urinary Tract Infection Rufloxacin Group","volume":"39","author":"Jardin","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0465","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1128\/AAC.42.9.2262","article-title":"Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin. The Sparfloxacin Multi Center UUTI Study Group","volume":"42","author":"Henry","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0470","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0149-2918(99)80018-6","article-title":"Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group","volume":"21","author":"Henry","year":"1999","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0475","first-page":"34","article-title":"The treatment of acute dysuria-frequency syndrome in adult women: double-blind, randomized comparison of three-day vs ten-day trimethoprim therapy","volume":"37","author":"Gossius G.V.L","year":"1985","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0480","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/13814780509178238","article-title":"Acute uncomplicated lower urinary tract infections in general practice: clinical and microbiological cure rates after three- versus five-day treatment trimethoprim","volume":"11","author":"van Merode","year":"2005","journal-title":"Eur J Gen Pract"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0485","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/00365548409073963","article-title":"A randomized comparison of single-dose vs. three-day and ten-day therapy with trimethoprim\u2013sulfamethoxazole for acute cystitis in women","volume":"16","author":"Gossius","year":"1984","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0505","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1128\/AAC.00837-08","article-title":"Intravenous therapy with doripenem versus levofloxacin with an option to switch to oral therapy for the treatment of complicated lower urinary tract infection and pyelonephritis","volume":"53","author":"Naber","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2011.09.003_bib0495","doi-asserted-by":"crossref","first-page":"ii67","DOI":"10.1093\/jac\/dkh208","article-title":"Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy","volume":"53","author":"Wells","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.09.003_bib0500","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0924-8579(01)00481-2","article-title":"Piperacillin 2g\/tazobactam 0.5g is as effective as imipenem 0.5g\/cilastatin 0.5g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections","volume":"19","author":"Naber","year":"2002","journal-title":"Int J Antimicrob Agents"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857911003621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857911003621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T11:25:34Z","timestamp":1639221934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857911003621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":100,"alternative-id":["S0924857911003621"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.09.003","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}